Kristina Lachance

4PUBLICATIONS
18CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 29, 2026
Immunotherapy Significantly Improves Merkel Cell Carcinoma-Specific Survival: A Single-Cohort Propensity Score-Matched Analysis.

|Sep 19, 2025
Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials.

Peter Y Ch'en, Yuzheng Zhang, Daniel S Hippe

|Aug 11, 2025
Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade.

Lisa Tachiki, Yasman Moshiri, Daniel S Hippe

|Dec 29, 2019
Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance.

Christopher W Lewis, Jamiluddin Qazi, Daniel S Hippe

Pageof 1

Frequent Collaborators

4 joint publications

Paul T Nghiem

2 joint publications

Daniel S Hippe

2 joint publications

Candice Church

2 joint publications

Tomoko Akaike